Rationale and design of ON-TRK: a novel prospective non-interventional study in patients with TRK fusion cancer treated with larotrectinib

  1. Yang, J.C.H.
  2. Brose, M.S.
  3. Castro, G.
  4. Kim, E.S.
  5. Lassen, U.N.
  6. Leyvraz, S.
  7. Pappo, A.
  8. López-Ríos, F.
  9. Reeves, J.A.
  10. Fellous, M.
  11. Penault-Llorca, F.
  12. Rudzinski, E.R.
  13. Tabatabai, G.
  14. Vassal, G.
  15. Drilon, A.
  16. Trent, J.
Revista:
BMC Cancer

ISSN: 1471-2407

Any de publicació: 2022

Volum: 22

Número: 1

Tipus: Article

DOI: 10.1186/S12885-022-09687-X GOOGLE SCHOLAR lock_openAccés obert editor
Font de les dades: Scopus